Björn Löwenadler
Corporate Officer/Principal at TOLERANZIA AB
Profile
Björn Löwenadler is currently the Director at Adjuvare AB and the Chief Business Officer at Toleranzia AB.
He previously held positions as an Independent Director at Alzinova AB, Director at Agrisera AB, Head of Discovery Sciences at AstraZeneca PLC, Head of Molecular Biology at Pharmacia Corp., Chief Scientific Officer at Arexis AB, and Head of Discovery Research at BioVitrum.
Dr. Löwenadler obtained a doctorate degree from Karolinska Institutet.
Björn Löwenadler active positions
| Companies | Position | Start |
|---|---|---|
| TOLERANZIA AB | Corporate Officer/Principal | - |
Adjuvare AB
 Adjuvare AB Miscellaneous Commercial ServicesCommercial Services Adjuvare AB is a Swedish company that offers biotechnology research and development services. | Director/Board Member | - |
Former positions of Björn Löwenadler
| Companies | Position | End |
|---|---|---|
Agrisera AB
 Agrisera AB Miscellaneous Commercial ServicesCommercial Services Part of Summa Equity AB, Agrisera AB is a Swedish company that produces primary and secondary antibodies for plant and algal cell biology research. The company is based in Vannas, Sweden and provides antibodies for plant and algal research, with prompt delivery worldwide, and reactivity to thousands of species. Agrisera ships worldwide and offers professional technical support. The company was founded in 1985. Erika Gelfgren has been the CEO of the company since 2012. | Director/Board Member | - |
| BioVitrum | Corporate Officer/Principal | - |
| ALZINOVA AB | Director/Board Member | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | - |
Training of Björn Löwenadler
| Karolinska Institutet | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| TOLERANZIA AB | Health Technology |
| ALZINOVA AB | Health Technology |
| Private companies | 5 |
|---|---|
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Health Technology |
| BioVitrum | |
Agrisera AB
Agrisera AB Miscellaneous Commercial ServicesCommercial Services Part of Summa Equity AB, Agrisera AB is a Swedish company that produces primary and secondary antibodies for plant and algal cell biology research. The company is based in Vannas, Sweden and provides antibodies for plant and algal research, with prompt delivery worldwide, and reactivity to thousands of species. Agrisera ships worldwide and offers professional technical support. The company was founded in 1985. Erika Gelfgren has been the CEO of the company since 2012. | Commercial Services |
Adjuvare AB
Adjuvare AB Miscellaneous Commercial ServicesCommercial Services Adjuvare AB is a Swedish company that offers biotechnology research and development services. | Commercial Services |
- Stock Market
- Insiders
- Björn Löwenadler
